US Patent Issued to University of Pittsburgh-Of the Commonwealth System of Higher Education on April 14 for "Treatment of Krabbe disease with umbilical cord blood transplantion (UCBT) and increased galactocerebrosidase (GALC) expression" (Pennsylvania Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,636, issued on April 14, was assigned to University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh).

"Treatment of Krabbe disease with umbilical cord blood transplantion (UCBT) and increased galactocerebrosidase (GALC) expression" was invented by Maria Luisa Escolar (Sewickley, Pa.) and Paul Szabolcs (Sewickley, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This application provides methods of treating Krabbe disease, for example in an infant. Such methods can include immunosuppressing the patient, for example by administration of a myeloablative regimen, administering an umbilical cord blood transplant (UCBT) (such a...